Phenotypic characterization of CD11b⁺Ly6C⁻ and CD11b⁺Ly6C⁺ lung DCs.

<p>A, Flow cytometric assessment of the expression levels of MHC-II, CD40, CD80, CD86, Sirp-α, FcεR-I, F4/80, CCR7, OX40L, ICOS-L, TIM-4, CD8α, Jagged-1 and Jagged-2 on the surface of CD11b⁺Ly6C⁺ and CD11b⁺Ly6C⁻ lung DCs from saline- and HDM-treated mice (n = 4 mice per group) (MFI, mean fluorescence intensity). B, ELISA measurement of the production of IL-6 and IL-12p40 by CD11b⁺Ly6C⁺ and CD11b⁺Ly6C⁻ lung DCs from HDM-treated mice.